What is Oppenheimer's price target for CSL?

Oppenheimer's latest stated price target for Carlisle Companies Incorporated (CSL) is $270, from its action on Dec 8, 2021.

What is Oppenheimer's rating on CSL?

Oppenheimer rates CSL Outperform, a bullish rating, as of Dec 8, 2021.

When did Oppenheimer last change its view on CSL?

On Dec 8, 2021, Oppenheimer raises its price target to $270 from $255, keeps Outperform.

Analyst firms · Oppenheimer · CSL

Oppenheimer CSL price target and rating history

Carlisle Companies Incorporated (CSL) · Industrials

Oppenheimer rates Carlisle Companies Incorporated (CSL) Outperform with a $270 price target, as of its latest action on Dec 8, 2021. It has published 4 rating actions on CSL since July 2021, including 0 upgrades and 0 downgrades.

Current rating: Outperform
Price target: $270
Median target, all firms: Too few
Actions on CSL: 4

Oppenheimer price target on CSL

Oppenheimer price target on CSL, each point a stated target, July 2021 to December 2021.

Every Oppenheimer rating on CSL

Dec 8, 2021
ReiterateOppenheimer raises its price target to $270 from $255, keeps Outperform
Oct 22, 2021
ReiterateOppenheimer raises its price target to $255 from $250, keeps Outperform
Jul 23, 2021
ReiterateOppenheimer raises its price target to $230 from $220, keeps Outperform
Jul 14, 2021
ReiterateOppenheimer raises its price target to $220 from $210, keeps Outperform

How other firms rate CSL

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
DA Davidson	Neutral	$410	Aug 25, 2026
Raymond James	Outperform	$425	Apr 28, 2026
William Blair	Mkt Perform		Jan 30, 2026

Questions about Oppenheimer and CSL

What is Oppenheimer's price target for CSL?: Oppenheimer's latest stated price target for Carlisle Companies Incorporated (CSL) is $270, from its action on Dec 8, 2021.
What is Oppenheimer's rating on CSL?: Oppenheimer rates CSL Outperform, a bullish rating, as of Dec 8, 2021.
When did Oppenheimer last change its view on CSL?: On Dec 8, 2021, Oppenheimer raises its price target to $270 from $255, keeps Outperform.

All Oppenheimer ratings CSL news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.